Oncopeptides begins NDA preparations for melflufen in triple-class refractory multiple myeloma May 21, 2019
Enrollment opens in new phase IIa study of CC-31244 for ultra-short treatment of hepatitis C May 21, 2019
Phase III KEYNOTE-119 trial of Keyruda in metastatic TNBC fails to meet primary endpoint May 21, 2019
RSS